Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-19

FDA Approved: FINGOLIMOD HYDROCHLORIDE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for fingolimod hydrochloride by Accord Healthcare Inc., authorizing a generic version of this multiple sclerosis therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod hydrochloride (Fingolimod hydrochloride)

Snippet

SUPPL AP for FINGOLIMOD HYDROCHLORIDE (FINGOLIMOD HYDROCHLORIDE)